What Researchers Did
Researchers investigated whether combining various chemotherapeutic agents with Fluosol-DA and different oxygenation conditions would enhance tumor growth delay.
What They Found
The study found that combining Fluosol-DA and carbogen breathing with various anticancer drugs significantly enhanced tumor growth delay compared to drug treatment with air breathing. The effectiveness of this enhancement was dependent on the specific drug, the level and duration of oxygenation, and the dosage of the perfluorochemical emulsion.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A key limitation is that this was a preclinical study conducted in 1988, meaning its findings are not directly transferable to human patients without further clinical investigation.